Lisinopril with Hydrochlorothiazide
- Product NDC
- 0143-1263
- 11-digit product format
- 001431263
- Labeler code
- 0143
- Product ID
- 0143-1263_4ac4e37f-7ce8-4ef8-a4ed-2b66a9b96713
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA076265
- Marketing category
- ANDA
- Marketing start
- 2002-07-08
- Marketing end
- 2023-01-18
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0143-1263-01 | 00143126301 | 100 TABLET in 1 BOTTLE, PLASTIC (0143-1263-01) | 100 tablet | 2002-07-08 | 2023-01-18 | No | No | Current |
| 0143-1263-10 | 00143126310 | 1000 TABLET in 1 BOTTLE, PLASTIC (0143-1263-10) | 1000 tablet | 2002-07-08 | 2023-01-18 | No | No | Current |